Our Mission

Human-Like Tissue

Utilizing a passionate and talented team, VoxCell is providing an extraordinary line of human-like tissue solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.

Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs in the pipeline fail), and impact the speed for new therapies to get to market. The successful translation between pre-clinical trial data and clinical trial results is less than 8% and we are on a mission to change that.

 

Testing on human-like tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.

Meet The Team

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO

Tim Cummings.png
Untitled design (3)_edited.png

Tim Cummings

Director of Engineering

Austyn Roelofs_edited.png
Untitled design (3)_edited.png

Austyn Roelofs

Lead Engineer

Benjamin Rampado.png
Untitled design (3)_edited.png

Benjamin Rampado

Chemist

Dan Wattier_edited.png
Untitled design (3)_edited.png

Dan Wattier

CBO

Renato Maureira.png
Untitled design (3)_edited.png

Renato Maureira

Admin, Finance & HR Coordinator

Charlotte Ellis.png
Untitled design (3)_edited.png

Charlotte Ellis, Ph.D.

Lead Chemist

Ian DeJong.png
Untitled design (3)_edited.png

Ian DeJong

Software Engineer

Kevin Vos.png
Untitled design (3)_edited.png

Kevin Vos, Ph.D.

Director of Preclinical R&D

Cameron Polglase_edited.png
Untitled design (3)_edited.png

Cameron Polglase

Lead Product Development Engineer

Megan Chisling.png
Untitled design (3)_edited.png

Megan Chisling

Product Development Engineer

CO-OP Students

Sue Youn Kim_edited.png
Untitled design (3)_edited.png

Sue Youn Kim

Tissue Engineering

Laura Lavallee_edited.png
Untitled design (3)_edited.png

Laura Lavallee

BioInk & Tissue Engineering

Jan McAslan.png
Untitled design (3)_edited.png

Jan McAslan

Engineering

ADvisors and partners

Alexandre Brolo.png
Untitled design (3)_edited.png

Alexandre Brolo, Ph.D.

Partner

Emma Davy.png
Untitled design (3)_edited.png

Emma Davy, Ph.D.

Advisor - Chemistry

Madhu Singh.png
Untitled design (3)_edited.png

Madhu Singh, Ph.D.

Advisor - Oncology

Nathan Lindquist.png
Untitled design (3)_edited.png

Nathan Lindquist, Ph.D.

Advisor - Optics.

Alvin Chubbs.png
Untitled design (3)_edited.png

Alvin Chubbs

Advisor - Business & Finance

Georgina Rizik_edited.png
Untitled design (3)_edited.png

Georgina Rizik, MBA.

Advisor - Strategy

Dave Leitch.png
Untitled design (3)_edited.png

Dave Leitch, Ph.D.

Advisor - Pharma

Curtis Evans.png
Untitled design (3)_edited.png

Curtis Evans

Advisor - Engineering

Board Members

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO, Board

Nina Vellani.png
Untitled design (3)_edited.png

Nina Vellani, Ph.D.

Board

Robert Levak.png
Untitled design (3)_edited.png

Robert Levak

Board